Tulane University - School of Medicine

Cindy A. Leissinger, M.D.
Professor of Medicine, Pediatrics and Pathology
Section of Hematology and Medical Oncology
Director, Louisiana Comprehensive Hemophilia Center
Medical Director, The Louisiana Center for Bleeding & Clotting Disorder
Co-Director, Coagulation Laboratory
TCC Program Member
cleissi@tulane.edu
(504) 988-5482, (504) 988-1600 fax
1430 Tulane Ave., Box SL-78, New Orleans, LA 70112-2699

Selected Publications:

Kahn MJ, Scher CD, Rozans MK, Leissinger CA, Michaels R, Krause J. Factor V Leiden is not responsible for stroke in patients with sickling disorders and is uncommon in African Americans with sickle cell disease. Am J Hematol 54:12-15 (1997)
Nguyen GT, Goedert JJ, Carrington M, Dean M, Aledort LM, Blatt PM, Cohen AF, DiMichele D, Eyster ME, Kessler C, Konkle B, Leissinger CA, Luban N, O'Brien S, O'Brien T. Phenotypic expressions of CCR5-delta-32 Homozygosity. J AIDS 22:75-82 (1999)
Leissinger CA, Becton D, Cornell C, and Gill JC. Stimate (Desmopressin Acetate) Nasal Spray, 1.5 mg/ml, for prevention and treatment of bleeding in patients with mild hemophilia A, mild and moderate type 1 von Willebrand disease, and symptomatic carriers of hemophilia A. Haemophilia 7:258-266 (2001)
Alonso-Rubiano E, Garber M, Friedman P, Hodges S, Leissinger CA. Hepatitis G virus in clotting factor concentrates. Haemophilia 9:110-115 (2003)

Tulane Cancer Center